Comparable stake leader
BlackRock, Inc.
SEC ownership of NEOGENOMICS INC
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001077183.
Disclosed value leader
BlackRock, Inc.
Comparable rows
50/50
Latest evidence
30 Jun 2026
- Public ticker
- NEO on Nasdaq
- Parsed ownership sources
-
13F and 13D/G
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
BlackRock, Inc.
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
50 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
BlackRock, Inc.
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
30 Jun 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001077183
- Issuer location
- Fort Myers, FL
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of NEOGENOMICS INC (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock, Inc.
Disclosed value leader
BlackRock, Inc.
Comparable rows
50/50
Latest evidence
30 Jun 2026
13F
13D/G
Lead comparable stake: 16%
13D/G row: BlackRock, Inc.
Showing 1-8 of 50 holder rows.
Quick read
BlackRock, Inc. leads the comparable SEC ownership view at 16%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership
Top 5
BlackRock, Inc.
16%
First Light Asset Management, LLC
8.4%
FIRST TRUST PORTFOLIOS LP
7.8%
Greenhouse Funds LLLP
7.1%
VANGUARD PORTFOLIO MANAGEMENT LLC
5.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
Company
|
16%
from 13D/G
|
$304,469,400
20,868,362 shares
|
— | 30 Jun 2026 |
| First Light Asset Management, LLC |
13F
13D/G
Company · Mathew P. Arens
|
8.4%
from 13D/G
|
$179,158,241
12,279,523 shares
|
— | 30 Jun 2026 |
| FIRST TRUST PORTFOLIOS LP |
13D/G
First Trust Portfolios L.P.
|
7.8%
|
$147,552,478
10,113,261 shares
|
$0 | 30 Jun 2026 |
| Greenhouse Funds LLLP |
13F
13D/G
Company
|
7.1%
from 13D/G
|
$125,097,724
8,574,210 shares
|
— | 30 Jun 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC |
13F
13D/G
Company · Vanguard Portfolio Management
|
5.9%
from 13D/G
|
$117,615,272
8,061,362 shares
|
— | 30 Jun 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
13D/G
Company · Vanguard Capital Management
|
5.1%
from 13D/G
|
$84,082,418
5,763,017 shares
|
— | 30 Jun 2026 |
| Janus Henderson Group Ltd. |
13D/G
JANUS HENDERSON GROUP PLC
|
4.8%
|
$63,315,197
6,165,063 shares
|
$0 | 31 Dec 2024 |
| INTEGRATED CORE STRATEGIES (US) LLC |
13D/G
Millennium Management LLC
|
2.8%
|
$26,073,366
3,566,808 shares
|
-$24,761,251 | 30 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$1,017,078.
Buys
$0
Insiders: 0
Sells
$1,017,078
Insiders: 4
Net
-$1,017,078
Shares: -78,576
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 78,576
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 30,614 | $0 | $440,224 | -$440,224 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 22,128 | $0 | $276,682 | -$276,682 |
| 9-12 | 0 | 25,834 | $0 | $300,172 | -$300,172 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 38 reporting-owner rows connected to NEOGENOMICS INC. Open a relationship link for the CIK-to-CIK filing trail.
Rows
38
Largest Forms 3/4/5 holder
Douglas M. van Oort
Net 12M change
-$1,017,078
Latest report
01 Sep 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Douglas M. van Oort | Director | $45,677,027 | Mixed | 01 Aug 2021 | ||
| Christopher M. Smith | Chief Executive Officer | $15,690,205 | Mixed | 23 Feb 2025 | ||
| Anthony P. Zook | Chief Executive Officer, Director | $9,421,907 | Mixed | 01 Apr 2026 | ||
| Warren Stone | Pres & Chief Operating Officer | $7,396,272 | -$276,682 | -3.6% | Mixed | 21 Aug 2026 |
| Mark Mallon | Chief Executive Officer, Director | $6,768,458 | Mixed | 01 Mar 2022 | ||
| Jeffrey Scott Sherman | Chief Financial Officer | $6,163,431 | Mixed | 21 Feb 2026 | ||
| Alicia C. Olivo | EVP, GC & Business Development | $5,685,369 | -$300,172 | -5% | Mixed | 01 Sep 2026 |
| George Cardoza | President & COO, Lab Ops | $4,857,847 | Mixed | 01 Mar 2022 | ||
| William Bonello | Chief Financial Officer | $3,522,568 | Mixed | 28 Apr 2022 | ||
| Douglas Matthew Brown | Chief Strategy Officer | $2,918,199 | Mixed | 01 Apr 2022 | ||
| Robert J. Shovlin | President, Clinical Services | $2,760,357 | Mixed | 25 May 2021 | ||
| Halley E. Gilbert | Chief Legal Officer | $2,710,612 | Mixed | 01 Mar 2022 | ||
| Vishal Sikri | President Advanced Diagnostics | $2,687,306 | Mixed | 23 Feb 2024 | ||
| Melody Harris | Chf Ops Off, Pres, Informatics | $2,353,925 | Mixed | 21 Feb 2025 | ||
| Shashikant Kulkarni | Chief Scientific Officer | $1,520,356 | Mixed | 01 Apr 2023 | ||
| Lynn A. Tetrault | Director | $1,476,221 | -$118,824 | -7.4% | Mixed | 15 Jun 2026 |
| Bruce K. Crowther | Director | $1,406,026 | Mixed | 10 Aug 2023 | ||
| Alison L. Hannah | Director | $1,201,755 | Mixed | 01 Jun 2025 | ||
| Michael Aaron Kelly | Director | $942,665 | Mixed | 01 Jun 2026 | ||
| Stephen M. Kanovsky | Director | $937,276 | Mixed | 01 Jun 2026 |
Recent insider transactions for NEOGENOMICS INC
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Alicia C. Olivo | NEO | Common Stock | Tax liability | -2.88% | -2,692 | 90,875 | 01 Sep 2026 | Direct | ||
| Warren Stone | NEO | Common Stock | Tax liability | -5.76% | -11,060 | 181,078 | 21 Aug 2026 | Direct | ||
| Warren Stone | NEO | Common Stock | Options Exercise | 17.1% | 28,106 | 192,138 | 21 Aug 2026 | Direct | ||
| Warren Stone | NEO | Restricted Stock Unit | Options Exercise | -50% | -28,106 | 28,106 | 21 Aug 2026 | Direct | ||
| Greg D. Aunan | NEO | Common Stock | Sale | -79.5% | $321,400 | $16.07 | -20,000 | 5,153 | 04 Aug 2026 | Direct |
| Carolyn S. Starrett | NEO | Restricted Stock Unit | Award | 14,125 | 14,125 | 23 Jun 2026 | Direct | |||
| Carolyn S. Starrett | NEO | Stock Option (Right to Buy) | Award | 9,784 | 9,784 | 23 Jun 2026 | Direct | |||
| Lynn A. Tetrault | NEO | Common Stock | Sale | -5.8% | $58,908 | $11.10 | -5,307 | 86,115 | 15 Jun 2026 | Direct |
| Lynn A. Tetrault | NEO | Common Stock | Sale | -5.49% | $59,916 | $11.29 | -5,307 | 91,422 | 09 Jun 2026 | Direct |
| John P. Kenny | NEO | Common Stock | Options Exercise | 5,893 | 5,893 | 01 Jun 2026 | Direct | |||
| John P. Kenny | NEO | Restricted Stock Unit | Award | 15,970 | 15,970 | 01 Jun 2026 | Direct | |||
| John P. Kenny | NEO | Stock Option (Right to Buy) | Award | 11,069 | 11,069 | 01 Jun 2026 | Direct | |||
| John P. Kenny | NEO | Restricted Stock Unit | Options Exercise | -100% | -5,893 | 0 | 01 Jun 2026 | Direct | ||
| Felicia Williams | NEO | Common Stock | Options Exercise | 322.3% | 23,077 | 30,237 | 01 Jun 2026 | Direct | ||
| Felicia Williams | NEO | Restricted Stock Unit | Award | 15,970 | 15,970 | 01 Jun 2026 | Direct | |||
| Felicia Williams | NEO | Stock Option (Right to Buy) | Award | 11,069 | 11,069 | 01 Jun 2026 | Direct | |||
| Felicia Williams | NEO | Restricted Stock Unit | Options Exercise | -100% | -23,077 | 0 | 01 Jun 2026 | Direct | ||
| Lynn A. Tetrault | NEO | Common Stock | Options Exercise | 31.3% | 23,077 | 96,729 | 01 Jun 2026 | Direct | ||
| Lynn A. Tetrault | NEO | Restricted Stock Unit | Award | 15,970 | 15,970 | 01 Jun 2026 | Direct | |||
| Lynn A. Tetrault | NEO | Stock Option (Right to Buy) | Award | 11,069 | 11,069 | 01 Jun 2026 | Direct | |||
| Lynn A. Tetrault | NEO | Restricted Stock Unit | Options Exercise | -100% | -23,077 | 0 | 01 Jun 2026 | Direct | ||
| David Brian Perez | NEO | Common Stock | Options Exercise | 68.1% | 23,077 | 56,967 | 01 Jun 2026 | Direct | ||
| David Brian Perez | NEO | Restricted Stock Unit | Award | 15,970 | 15,970 | 01 Jun 2026 | Direct | |||
| David Brian Perez | NEO | Stock Option (Right to Buy) | Award | 11,069 | 11,069 | 01 Jun 2026 | Direct | |||
| David Brian Perez | NEO | Restricted Stock Unit | Options Exercise | -100% | -23,077 | 0 | 01 Jun 2026 | Direct | ||
| Michael Aaron Kelly | NEO | Common Stock | Options Exercise | 52.4% | 23,077 | 67,086 | 01 Jun 2026 | Direct | ||
| Michael Aaron Kelly | NEO | Restricted Stock Unit | Award | 15,970 | 15,970 | 01 Jun 2026 | Direct | |||
| Michael Aaron Kelly | NEO | Stock Option (Right to Buy) | Award | 11,069 | 11,069 | 01 Jun 2026 | Direct | |||
| Michael Aaron Kelly | NEO | Restricted Stock Unit | Options Exercise | -100% | -23,077 | 0 | 01 Jun 2026 | Direct | ||
| Stephen M. Kanovsky | NEO | Common Stock | Options Exercise | 44.1% | 23,077 | 75,421 | 01 Jun 2026 | Direct | ||
| Stephen M. Kanovsky | NEO | Restricted Stock Unit | Award | 15,970 | 15,970 | 01 Jun 2026 | Direct | |||
| Stephen M. Kanovsky | NEO | Stock Option (Right to Buy) | Award | 11,069 | 11,069 | 01 Jun 2026 | Direct | |||
| Stephen M. Kanovsky | NEO | Restricted Stock Unit | Options Exercise | -100% | -23,077 | 0 | 01 Jun 2026 | Direct | ||
| Neil Gunn | NEO | Common Stock | Options Exercise | 82.1% | 23,077 | 51,177 | 01 Jun 2026 | Direct | ||
| Neil Gunn | NEO | Restricted Stock Unit | Award | 15,970 | 15,970 | 01 Jun 2026 | Direct | |||
| Neil Gunn | NEO | Stock Option (Right to Buy) | Award | 11,069 | 11,069 | 01 Jun 2026 | Direct | |||
| Neil Gunn | NEO | Restricted Stock Unit | Options Exercise | -100% | -23,077 | 0 | 01 Jun 2026 | Direct | ||
| Marjorie C. Green | NEO | Common Stock | Options Exercise | 22,964 | 22,964 | 01 Jun 2026 | Direct | |||
| Marjorie C. Green | NEO | Restricted Stock Unit | Award | 15,970 | 15,970 | 01 Jun 2026 | Direct | |||
| Marjorie C. Green | NEO | Stock Option (Right to Buy) | Award | 11,069 | 11,069 | 01 Jun 2026 | Direct | |||
| Marjorie C. Green | NEO | Restricted Stock Unit | Options Exercise | -100% | -22,964 | 0 | 01 Jun 2026 | Direct | ||
| Alicia C. Olivo | NEO | Common Stock | Tax liability | -2.66% | -2,559 | 93,567 | 11 May 2026 | Direct | ||
| Alicia C. Olivo | NEO | Common Stock | Options Exercise | 4.28% | 3,944 | 96,126 | 11 May 2026 | Direct | ||
| Alicia C. Olivo | NEO | Restricted Stock Unit | Options Exercise | -60.6% | -3,944 | 2,559 | 11 May 2026 | Direct | ||
| Warren Stone | NEO | Common Stock | Tax liability | -2.25% | -3,783 | 164,032 | 11 May 2026 | Direct | ||
| Warren Stone | NEO | Common Stock | Options Exercise | 3.6% | 5,830 | 167,815 | 11 May 2026 | Direct | ||
| Warren Stone | NEO | Restricted Stock Unit | Options Exercise | -60.6% | -5,830 | 3,783 | 11 May 2026 | Direct | ||
| Greg D. Aunan | NEO | Common Stock | Tax liability | -4.95% | -1,309 | 25,153 | 02 May 2026 | Direct | ||
| Greg D. Aunan | NEO | Common Stock | Options Exercise | 25.5% | 5,372 | 26,462 | 02 May 2026 | Direct | ||
| Greg D. Aunan | NEO | Restricted Stock Unit | Options Exercise | -33.3% | -5,372 | 10,745 | 02 May 2026 | Direct |
* marks a reported price that did not pass the local price check.